Effectiveness of immunosuppressant use for the treatment of immune checkpoint inhibitor-induced liver injury: A systematic review and meta-analysis

BACKGROUND: Immune-mediated liver injury caused by checkpoint inhibitors (ILICI) is a challenging clinical management issue. Although immunosuppressants are widely used to manage ILICI, no large-scale studies have proved definitive evidence for the most effective form of patient management. AIM: Ana...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Kefan, He, Junhao, Xu, Jing, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080119/
https://www.ncbi.nlm.nih.gov/pubmed/37035152
http://dx.doi.org/10.3389/fonc.2023.1088741

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10080119/
https://www.ncbi.nlm.nih.gov/pubmed/37035152
http://dx.doi.org/10.3389/fonc.2023.1088741

Ejemplares similares